STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

STJ

1,199

+1.05%↑

HIK

1,404.5

+1.08%↑

HILS

2,490

-3.11%↓

Search

GlaxoSmithKline PLC

Fechado

SetorSaúde

1,846.25 0.29

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1841

Máximo

1869.25

Indicadores-chave

By Trading Economics

Rendimento

1.2B

1.8B

Vendas

-989M

7.6B

P/E

Médio do Setor

13.387

49.8

EPS

0.465

Rendimento de Dividendos

3.47

Margem de lucro

24.105

Funcionários

66,841

EBITDA

577M

2.8B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+7.24% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.47%

2.25%

Próximos Ganhos

29 de jul. de 2026

Próxima data de dividendos

9 de jul. de 2026

Próxima data de ex-dividendo

14 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-4.2B

76B

Abertura anterior

1845.96

Fecho anterior

1846.25

Sentimento de Notícias

By Acuity

56%

44%

271 / 347 Ranking em Healthcare

GlaxoSmithKline PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de abr. de 2026, 06:42 UTC

Ganhos

GSK Earnings Boosted by Higher Specialty Medicine Sales

6 de mai. de 2026, 13:35 UTC

Conversa de Mercado

GSK Is Taking Steps in Right Direction, But Might Need More -- Market Talk

29 de abr. de 2026, 10:39 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

GSK CEO Sees RAPT Therapeutics Acquisition as Template for Future Deals -- Market Talk

29 de abr. de 2026, 10:06 UTC

Conversa de Mercado
Ganhos

AstraZeneca, GSK Results Fail to Impress Market -- Market Talk

29 de abr. de 2026, 10:02 UTC

Conversa de Mercado
Ganhos

GSK Makes Ideal Start for New CEO -- Market Talk

29 de abr. de 2026, 06:07 UTC

Ganhos

GSK PLC Sees 70p 2026 Dividend Payout

29 de abr. de 2026, 06:07 UTC

Ganhos

GSK PLC Declares Dividend of 17p

29 de abr. de 2026, 06:07 UTC

Ganhos

GSK PLC Free Cash Flow of GBP0.8B

29 de abr. de 2026, 06:06 UTC

Ganhos

GSK PLC Cash Generated From Operations GBP1.4B

29 de abr. de 2026, 06:06 UTC

Ganhos

GSK PLC 1Q General Medicines Sales GBP2.3B

29 de abr. de 2026, 06:06 UTC

Ganhos

GSK PLC 1Q Vaccines Sales GBP2.1B

29 de abr. de 2026, 06:06 UTC

Ganhos

GSK PLC 1Q Specialty Medicines Sales GBP3.2B

29 de abr. de 2026, 06:05 UTC

Ganhos

Analysts Saw GSK PLC 1Q Net Profit at GBP1.74B

29 de abr. de 2026, 06:04 UTC

Ganhos

Analysts Saw GSK 1Q Adjusted Operating Profit of GBP2.46B

29 de abr. de 2026, 06:04 UTC

Ganhos

GSK PLC 1Q Adjusted Operating Profit GBP2.65B

29 de abr. de 2026, 06:04 UTC

Ganhos

Analysts Saw GSK PLC Core EPS of 43.3p

29 de abr. de 2026, 06:04 UTC

Ganhos

Analysts Saw GSK PLC 1Q Turnover at GBP7.58B

29 de abr. de 2026, 06:04 UTC

Ganhos

GSK PLC 1Q Adj EPS 46.50p

29 de abr. de 2026, 06:01 UTC

Ganhos

GSK PLC Sees 2026 Adjusted EPS Growth of 7%-9%

29 de abr. de 2026, 06:01 UTC

Ganhos

GSK PLC Sees 2026 Adjusted Oper Pft Growth of 7%-9%

29 de abr. de 2026, 06:01 UTC

Ganhos

GSK PLC Sees 2026 Turnover Growth of 3%-5%

29 de abr. de 2026, 06:01 UTC

Ganhos

GSK PLC Backs 2026 View

29 de abr. de 2026, 06:00 UTC

Ganhos

GSK PLC 1Q EPS 42.6p

29 de abr. de 2026, 06:00 UTC

Ganhos

GSK PLC 1Q Turnover GBP7.63B

29 de abr. de 2026, 06:00 UTC

Ganhos

GSK PLC 1Q Pretax Pft GBP2.14B

29 de abr. de 2026, 06:00 UTC

Ganhos

GSK PLC 1Q Oper Pft GBP2.29B

29 de abr. de 2026, 06:00 UTC

Ganhos

GSK PLC 1Q Net Pft GBP1.74B

15 de abr. de 2026, 06:12 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK Completes Acquisition of 35Pharma

10 de abr. de 2026, 10:43 UTC

Conversa de Mercado

GSK Could Report Weak General Medicines Results -- Market Talk

31 de mar. de 2026, 14:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Samsung Biologics Will Continue Supplying Products Previously Manufactured at Site to GSK Under Terms of Agreement

Comparação entre Pares

Variação de preço

GlaxoSmithKline PLC Previsão

Preço-alvo

By TipRanks

7.24% parte superior

Previsão para 12 meses

Média 1,976.36 GBX  7.24%

Máximo 2,630 GBX

Mínimo 1,500 GBX

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para GlaxoSmithKline PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

13 ratings

3

Comprar

7

Manter

3

Vender

Sentimento

By Acuity

271 / 347 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
help-icon Live chat